Wall Street RegretsThe regret calculator.

What if you'd held BIIB?

A $1,000 investment in Biogen Inc. (BIIB) at the month-end close of 1991-09 would be worth $70,899 at the close of 2026-08 — +6989.9% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $19,873.

$1,000 since 1991$70,899Total return+6989.9%Multiple70.9×CAGR+13.0%

Your scenario

Daily precision available for this ticker.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$70,899Gain+$69,899 (+6989.9%)Multiple70.9×CAGR+13.0%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included. Click any year for the full story.

    Every year, $1,000 from 1991

    YearValue of $1,000Year return
    1991$1,000
    1992$673-32.7%
    1993$442-34.3%
    1994$163-63.0%
    1995$1,500+818.1%
    1996$1,826+21.8%
    1997$2,644+44.7%
    1998$3,615+36.7%
    1999$15,113+318.1%
    2000$29,159+92.9%
    2001$31,809+9.1%
    2002$15,307-51.9%
    2003$16,936+10.6%
    2004$30,738+81.5%
    2005$20,895-32.0%
    2006$22,700+8.6%
    2007$26,267+15.7%
    2008$21,980-16.3%
    2009$24,689+12.3%
    2010$30,941+25.3%
    2011$50,784+64.1%
    2012$67,545+33.0%
    2013$129,012+91.0%
    2014$156,645+21.4%
    2015$141,371-9.8%
    2016$130,863-7.4%
    2017$147,010+12.3%
    2018$138,865-5.5%
    2019$136,931-1.4%
    2020$112,995-17.5%
    2021$110,715-2.0%
    2022$127,790+15.4%
    2023$119,414-6.6%
    2024$70,568-40.9%
    2025$81,214+15.1%
    2026$102,243+25.9%

    Best and worst month-end to buy

    The best single month-end close to have bought BIIB was 1994-12 ($0.35): $1,000 then is $625,876 today. The worst was 2015-03 ($422): $1,000 then is $525.

    FAQ

    What would $1,000 in BIIB be worth today?

    A $1,000 investment in Biogen Inc. (BIIB) at the start of 1991 would be worth about $70,899 today, a total return of +6989.9%. Dividends are reinvested in these figures.

    What were the best and worst years for BIIB?

    Biogen Inc. (BIIB)'s strongest calendar year since 1991 was 1995, a +818.1% return — $1,000 held through that year became about $9,181 by year-end. Its weakest year was 1994, at -63.0%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in BIIB have grown?

    Investing $100 at the end of every month since 1991-09 would have grown to about $1.61M on $42,000 invested.

    Did BIIB beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $19,873. BIIB beat the S&P 500 by +256.8% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Biogen Inc. (BIIB) historical total-return data from 1991-09 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.